Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin

NCT01913964 is registered in ClinicalTrials.gov with University of Catania as lead sponsor.

NCT NCT01913964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01913964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin
Lead sponsor
University of Catania
Phase
Phase 4
Overall status
Completed
Start date
October 31, 1997
Completion date
October 31, 1997
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, fatigue in workers with chronic c hepatitis, work productivity and activity impairment in workers with chronic c hepatitis